Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence.
Yan W, Jamal M, Tan SH, Song Y, Young D, Chen Y, Katta S, Ying K, Ravindranath L, Woodle T, Kohaar I, Cullen J, Kagan J, Srivastava S, Dobi A, McLeod DG, Rosner IL, Sesterhenn IA, Srinivasan A, Srivastava S, Petrovics G. Yan W, et al. Among authors: kagan j. Oncotarget. 2019 Nov 5;10(60):6466-6483. doi: 10.18632/oncotarget.27294. eCollection 2019 Nov 5. Oncotarget. 2019. PMID: 31741711 Free PMC article.
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
Rastogi A, Tan SH, Mohamed AA, Chen Y, Hu Y, Petrovics G, Sreenath T, Kagan J, Srivastava S, McLeod DG, Sesterhenn IA, Srivastava S, Dobi A, Srinivasan A. Rastogi A, et al. Among authors: kagan j. Genes Cancer. 2014 Jul;5(7-8):273-84. doi: 10.18632/genesandcancer.25. Genes Cancer. 2014. PMID: 25221645 Free PMC article.
Predominance of ERG-negative high-grade prostate cancers in African American men.
Farrell J, Young D, Chen Y, Cullen J, Rosner IL, Kagan J, Srivastava S, McLEOD DG, Sesterhenn IA, Srivastava S, Petrovics G. Farrell J, et al. Among authors: kagan j. Mol Clin Oncol. 2014 Nov;2(6):982-986. doi: 10.3892/mco.2014.378. Epub 2014 Aug 7. Mol Clin Oncol. 2014. PMID: 25279185 Free PMC article.
Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.
He J, Schepmoes AA, Shi T, Wu C, Fillmore TL, Gao Y, Smith RD, Qian WJ, Rodland KD, Liu T, Camp DG 2nd, Rastogi A, Tan SH, Yan W, Mohamed AA, Huang W, Banerjee S, Kagan J, Srivastava S, McLeod DG, Srivastava S, Petrovics G, Dobi A, Srinivasan A. He J, et al. Among authors: kagan j. J Transl Med. 2015 Feb 12;13:54. doi: 10.1186/s12967-015-0418-z. J Transl Med. 2015. PMID: 25889691 Free PMC article.
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.
Petrovics G, Li H, Stümpel T, Tan SH, Young D, Katta S, Li Q, Ying K, Klocke B, Ravindranath L, Kohaar I, Chen Y, Ribli D, Grote K, Zou H, Cheng J, Dalgard CL, Zhang S, Csabai I, Kagan J, Takeda D, Loda M, Srivastava S, Scherf M, Seifert M, Gaiser T, McLeod DG, Szallasi Z, Ebner R, Werner T, Sesterhenn IA, Freedman M, Dobi A, Srivastava S. Petrovics G, et al. Among authors: kagan j. EBioMedicine. 2015 Oct 31;2(12):1957-64. doi: 10.1016/j.ebiom.2015.10.028. eCollection 2015 Dec. EBioMedicine. 2015. PMID: 26844274 Free PMC article.
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.
Rastogi A, Ali A, Tan SH, Banerjee S, Chen Y, Cullen J, Xavier CP, Mohamed AA, Ravindranath L, Srivastav J, Young D, Sesterhenn IA, Kagan J, Srivastava S, McLeod DG, Rosner IL, Petrovics G, Dobi A, Srivastava S, Srinivasan A. Rastogi A, et al. Among authors: kagan j. Genes Cancer. 2016 Nov;7(11-12):394-413. doi: 10.18632/genesandcancer.126. Genes Cancer. 2016. PMID: 28191285 Free PMC article.
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.
Cullen J, Young D, Chen Y, Degon M, Farrell J, Sedarsky J, Baptiste W, Rosen P, Tolstikov V, Kiebish M, Kagan J, Srivastava S, Kuo HC, Moncur JT, Rosner IL, Narain N, Akmaev V, Petrovics G, Dobi A, McLeod DG, Srivastava S, Sesterhenn IA. Cullen J, et al. Among authors: kagan j. Eur Urol Focus. 2018 Dec;4(6):818-824. doi: 10.1016/j.euf.2017.02.016. Epub 2017 Mar 11. Eur Urol Focus. 2018. PMID: 28753864 Free PMC article.
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression.
Gao Y, Wang YT, Chen Y, Wang H, Young D, Shi T, Song Y, Schepmoes AA, Kuo C, Fillmore TL, Qian WJ, Smith RD, Srivastava S, Kagan J, Dobi A, Sesterhenn IA, Rosner IL, Petrovics G, Rodland KD, Srivastava S, Cullen J, Liu T. Gao Y, et al. Among authors: kagan j. Cancers (Basel). 2020 May 17;12(5):1268. doi: 10.3390/cancers12051268. Cancers (Basel). 2020. PMID: 32429558 Free PMC article.
ERG monoclonal antibody in the diagnosis and biological stratification of prostate cancer: delineation of minimal epitope, critical residues for binding, and molecular basis of specificity.
Rastogi A, Tan SH, Banerjee S, Sharad S, Kagan J, Srivastava S, McLeod DG, Srivastava S, Srinivasan A. Rastogi A, et al. Among authors: kagan j. Monoclon Antib Immunodiagn Immunother. 2014 Aug;33(4):201-8. doi: 10.1089/mab.2014.0026. Monoclon Antib Immunodiagn Immunother. 2014. PMID: 25170998
533 results